MAP
AMED

Moody Aldrich Partners’s Amedisys AMED Stock Holding History

Moody Aldrich Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,054
Closed -$2.95M – 161
2020
Q1 		$2.95M Sell
16,054
-19
-0.1% -$3.38K 0.89% 46
2019
Q4 		$2.68M Buy
16,073
+136
+0.9% +$20.2K 0.55% 74
2019
Q3 		$2.09M Sell
15,937
-178
-1% -$23.2K 0.56% 70
2019
Q2 		$1.96M Sell
16,115
-12,258
-43% -$1.45M 0.5% 75
2019
Q1 		$3.5M Buy
28,373
+11,072
+64% +$1.39M 0.98% 48
2018
Q4 		$2.03M Sell
17,301
-4,545
-21% -$536K 0.67% 62
2018
Q3 		$2.73M Sell
21,846
-45,453
-68% -$5.02M 0.79% 62
2018
Q2 		$5.75M Buy
+67,299
New +$4.94M 2.04% 5

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Moody Aldrich Partners's AMED Position: Q2 2020 in Review

Moody Aldrich Partners sold out of Amedisys (AMED) in Q2 2020, closing a stake of 16,054 shares — an estimated $2.95M sold.

Moody Aldrich Partners first reported a position in AMED in Q2 2018 and held it in 8 quarters. The position peaked at $5.75M in Q2 2018. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Moody Aldrich Partners reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Moody Aldrich Partners sold 16,054 Amedisys shares in Q2 2020, an estimated $2.95M.
  • Moody Aldrich Partners first reported a position in Amedisys in Q2 2018 and held it in 8 quarters.
  • Moody Aldrich Partners's Amedisys position peaked at $5.75M in Q2 2018.
  • 354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Moody Aldrich Partners's 13F filing for Q2 2020, filed 30 Jul 2020.